Total Payments
$83,737
2024 Payments
$23,689
Companies
3
Transactions
86
Payment Breakdown by Category
Other$41,642 (49.7%)
Education$18,404 (22.0%)
Consulting$12,601 (15.0%)
Travel$8,748 (10.4%)
Food & Beverage$2,341 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,142 | 13 | 46.7% |
| Education | $18,404 | 26 | 22.0% |
| Consulting Fee | $12,601 | 5 | 15.0% |
| Travel and Lodging | $8,748 | 24 | 10.4% |
| Honoraria | $2,500 | 1 | 3.0% |
| Food and Beverage | $2,341 | 17 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | $76,028 | 76 | $0 (2024) |
| GENZYME CORPORATION | $7,692 | 9 | $0 (2023) |
| Greenwich Biosciences, Inc. | $16.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,689 | 9 | BioMarin Pharmaceutical Inc. ($23,689) |
| 2023 | $8,184 | 10 | GENZYME CORPORATION ($7,692) |
| 2022 | $17,981 | 15 | BioMarin Pharmaceutical Inc. ($17,981) |
| 2021 | $16.82 | 1 | Greenwich Biosciences, Inc. ($16.82) |
| 2020 | $4,000 | 1 | BioMarin Pharmaceutical Inc. ($4,000) |
| 2019 | $1,849 | 4 | BioMarin Pharmaceutical Inc. ($1,849) |
| 2018 | $7,835 | 12 | BioMarin Pharmaceutical Inc. ($7,835) |
| 2017 | $20,181 | 34 | BioMarin Pharmaceutical Inc. ($20,181) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 12/31/2024 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $2,967.18 | General |
| 11/08/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: PKU | ||||||
| 05/23/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,942.44 | General |
| Category: PKU | ||||||
| 04/19/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,100.00 | General |
| Category: PKU | ||||||
| 04/19/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Food and Beverage | In-kind items and services | $75.12 | General |
| Category: PKU | ||||||
| 03/12/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,100.00 | General |
| Category: PKU | ||||||
| 03/12/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Travel and Lodging | In-kind items and services | $1,891.78 | General |
| Category: PKU | ||||||
| 03/12/2024 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Food and Beverage | In-kind items and services | $45.52 | General |
| Category: PKU | ||||||
| 12/31/2023 | BioMarin Pharmaceutical Inc. | — | Consulting Fee | Cash or cash equivalent | $491.78 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $5,775.00 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $639.51 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $540.14 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $332.00 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $105.00 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 12/11/2023 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $30.59 | General |
| 12/16/2022 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,400.00 | General |
| Category: PKU | ||||||
| 12/06/2022 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Travel and Lodging | In-kind items and services | $744.58 | General |
| Category: PKU | ||||||
| 12/06/2022 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Food and Beverage | In-kind items and services | $126.00 | General |
| Category: PKU | ||||||
| 12/06/2022 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Travel and Lodging | In-kind items and services | $103.50 | General |
| Category: PKU | ||||||
| 12/06/2022 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Travel and Lodging | In-kind items and services | $51.75 | General |
| Category: PKU | ||||||
| 11/23/2022 | BioMarin Pharmaceutical Inc. | Palynziq (Drug), Kuvan | Travel and Lodging | In-kind items and services | $101.68 | General |
| Category: PKU | ||||||
About Dr. Deborah Bilder, M.D
Dr. Deborah Bilder, M.D is a Neurodevelopmental Disabilities healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427084615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Bilder, M.D has received a total of $83,737 in payments from pharmaceutical and medical device companies, with $23,689 received in 2024. These payments were reported across 86 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,142).
Ad
Practice Information
- Specialty Neurodevelopmental Disabilities
- Location Salt Lake City, UT
- Active Since 06/23/2006
- Last Updated 10/28/2021
- Taxonomy Code 2084P0005X
- Entity Type Individual
- NPI Number 1427084615
Products in Payments
- Palynziq (Drug) $27,679
- Kuvan (Drug) $17,980
- BMN 165 (Biological) $11,240
- Epidiolex (Drug) $16.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.